Funding healthcare and Tamiflu recall: evidence sessions
20 October 2014
The Public Accounts Committee are holding two evidence sessions. The first is for the Committee’s inquiry on the NAO report into Funding healthcare: making allocations to the local area. The second is for Tamiflu recall.
- Parliament TV: Funding healthcare: making allocations to local areas and Tamiflu recall
- Inquiry: Funding healthcare: making allocations to local areas
- Inquiry: Tamiflu recall
- Public Accounts Committee
Witnesses
Monday 20 October 2014, Committee Room 15, Palace of Westminster
Funding healthcare: making allocations to the local area
3.15pm:
- Una O’Brien, Permanent Secretary, Department of Health
- Richard Douglas, Director General of Finance and NHS, Department of Health
- Simon Stevens, Chief Executive, NHS England
- Paul Baumann, Chief Finance Office, NHS England
Tamiflu recall
5.00pm:
- Una O’Brien, Permanent Secretary, Department of Health
- Professor Dame Sally Davies, Chief Medical Office, Department of Health
- Sir Andrew Dillon, Chief Executive, National Institute for Health and Care Excellence
- Dr Ian Hudson, Chief Executive, Medicines and Healthcare Products Regulatory Agency
- Professor Carl Heneghan, Director, Centre for Evidence-based Medicine, University of Oxford
- Dr Fiona Godlee, Editor-in-Chief, British Medical Journal